0000914190-20-000074.txt : 20200214
0000914190-20-000074.hdr.sgml : 20200214
20200214161559
ACCESSION NUMBER: 0000914190-20-000074
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20200212
FILED AS OF DATE: 20200214
DATE AS OF CHANGE: 20200214
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Points Jeffrey S.
CENTRAL INDEX KEY: 0001731414
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 000-52082
FILM NUMBER: 20620069
MAIL ADDRESS:
STREET 1: C/O CARDIOVASCULAR SYSTEMS, INC.
STREET 2: 1225 OLD HIGHWAY 8 NW
CITY: ST. PAUL
STATE: MN
ZIP: 55112
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Cardiovascular Systems Inc
CENTRAL INDEX KEY: 0001180145
STANDARD INDUSTRIAL CLASSIFICATION: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841]
IRS NUMBER: 411698056
STATE OF INCORPORATION: DE
FISCAL YEAR END: 0630
BUSINESS ADDRESS:
STREET 1: 1225 OLD HWY 8 NW
CITY: ST. PAUL
STATE: MN
ZIP: 55112
BUSINESS PHONE: 651-259-1600
MAIL ADDRESS:
STREET 1: 1225 OLD HWY 8 NW
CITY: ST. PAUL
STATE: MN
ZIP: 55112
FORMER COMPANY:
FORMER CONFORMED NAME: REPLIDYNE INC
DATE OF NAME CHANGE: 20020813
4
1
edgar.xml
PRIMARY DOCUMENT
X0306
4
2020-02-12
0001180145
Cardiovascular Systems Inc
CSII
0001731414
Points Jeffrey S.
1225 OLD HIGHWAY 8 NW
ST. PAUL
MN
55112
0
1
0
0
Chief Financial Officer
Common Stock
2019-08-09
5
G
0
1055
0
D
53613
D
Common Stock
2020-02-12
4
S
0
3000
42.1785
D
50613
D
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $42.015 to $42.36 inclusive. The reporting person undertakes to provide Cardiovascular Systems, Inc., any security holder of Cardiovascular Systems, Inc., or the staff of the Securities and Exchange Commission upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
/s/ Amanda Lorentz as Attorney-in-Fact for Jeffrey S. Points pursuant to Power of Attorney previously filed.
2020-02-14